• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biora Therapeutics, Inc. - Common Stock (NQ: BIOR )

    0.6554 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 160
    Open 0.6554
    Bid (Size) 0.6201 (8)
    Ask (Size) 0.6490 (1)
    Prev. Close 0.6554
    Today's Range 0.6554 - 0.6554
    52wk Range 0.5850 - 6.700
    Shares Outstanding 4,063,081
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga

    Performance

    YTD
    -50.72%
    -50.72%
    1 Month
    -10.87%
    -10.87%
    3 Month
    -31.76%
    -31.76%
    6 Month
    -66.30%
    -66.30%
    1 Year
    -71.87%
    -71.87%

    More News

    Read More
    Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics: Q4 Earnings Insights
    Via Benzinga
    Earnings Outlook For Biora Therapeutics
    Via Benzinga
    Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    BIOR Stock Earnings: Biora Therapeutics Misses EPS for Q4 2023
    Via InvestorPlace
    Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 26, 2024
    Via Benzinga
    Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Biora Therapeutics Provides Outlook for 2024
    From Biora Therapeutics, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.